A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease.

ABSTRACT:

Introduction

Patients treated with biologics for inflammatory bowel disease (IBD) have an increased risk of severe infections. Real-life vaccination coverage in this population remains low despite international vaccination guidelines. The aim of this study was to evaluate the impact of a dedicated vaccination visit on vaccination coverage.

Methods

A dedicated vaccination visit was offered to all patients admitted for an infusion of a biologic in a tertiary IBD center during a 4-week period. At baseline, vaccination status was collected. Patients received specific information on recommended vaccinations. Perceived utility of both vaccination and the dedicated visit were assessed by visual analogue scale (VAS). Vaccination coverage was reassessed 6 months later by phone call.<

SUBMITTER: Le Cosquer G 

PROVIDER: S-EPMC9039447 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature